The
2nd Business Today – Yes Bank SME Survey and Awards 2010 was held at
New Delhi on 28th October 2010. These Awards have been designed to
analyze trends and best practices and to recognize and reward
achievers...
Veeda
is pleased to announce the new opening of the state-of-the-art facility
at Ahmedabad, India. The facility is located within 5km of the
existing....
Veeda
Clinical Research Ltd. Plymouth, UK has been certified under the French
Research Tax Credit for Research and Development activities
Category......
VEEDA CR, India’s
fastest growing Clinical Research
Organisation (CRO), has recently
cleared the ANVISA inspection for
the fourth consecutive time without
any findings, which enables Veeda to
continue conducting studies for
drugs to be marketed in Brazil....
The 2009 Frost &
Sullivan Award for Indian Clinical
Research Company of the Year is
presented to Veeda Clinical
Research. The award recognizes Veeda
for significant growth in the
Clinical Research segment,...
Veeda
UK today announced that it is been awarded Supplementary accreditation
for conducting clinical pharmacology Phase I Trials in Europe by the
Medicines and Healthcare products Regulatory Agency (MHRA)...
Veeda
UK today announced that it is been awarded Supplementary accreditation
for conducting clinical pharmacology Phase I Trials in Europe by the
Medicines and Healthcare products Regulatory Agency (MHRA)...
At the recent
National Conference for Clinical
Research held in Penang, Malaysia,
Veeda Clinical Research and the
Malaysian Ministry of Health
announced the opening of Veeda’s
office in South East Asia and a
collaborative agreement with the
Malaysian Ministry Health..
Veeda Clinical Research® is a full service global CRO specializing in the early clinical development of drugs. With state-of-the-art facilities in India, the US, Malaysia and Belgium, we provide a full range of services in phase I and IIa clinical research, delivering expert, cost effective research solutions to the Pharmaceutical and Biotechnology Industries worldwide. We have a capacity of over 200 beds globally including a specialized oncology focused phase 1 facility in an academic hospital in the US.
Veeda CR has over 20 years experience in clinical research and as the largest phase 1 CRO in India we provide our clients with access to the vast populations, excellent turnaround times and economies of India with the complete reassurance of an experienced project management service. Whether this is your first step into Asia or you have chosen to strategically spread a program of work across continents, Veeda CR has the capabilities and expertise to take your compound from Pre-clinical all the way to Proof of Concept.
Veeda CR has been inspected by the FDA, MHRA and WHO and is DCGI and ANVISA approved, as well as winner of Frost and Sullivan’s “Indian Clinical Research Organization of the Year 2009” and Frost and Sullivan’s “Partner of Choice” for phase I studies in 2007.
